Development and validation of a new, sensitive immunochemical assay for O6-methylguanine in DNA and its application in a population study

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 1, 2011, Pages 82-90

  Georgiadis, Panagiotis ^a   Kaila, Stella ^a   Makedonopoulou, Paraskevi ^a   Fthenou, Eleni ^b   Chatzi, Leda ^b   Pletsa, Vasiliki ^a   Kyrtopoulos, Soterios A ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

6 O METHYLGUANINE; ANTISERUM; DNA FRAGMENT; NITROSO DERIVATIVE; NUCLEOTIDE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MOTHER; NONHUMAN; OBSERVATION; POPULATION RESEARCH; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; UMBILICAL CORD BLOOD; VALIDATION PROCESS; WASTE;

ANIMALS; BLOOD BUFFY COAT; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; GUANINE; HELA CELLS; HUMANS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 78651445629     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0788     Document Type: Article

References (34)

1. 6-alkylguanine-DNA alkyltransferase activities in gastric mucosa and circulating lymphocytes. Carcinogenesis 1990;11:431-6
2. Badawi AF, Mostafa MH, Aboul-Azm T, Haboubi NY, O'Connor PJ, Cooper DP. Promutagenic methylation damage in bladder DNA from patients with bladder cancer associated with schisto- somiasis and from normal individuals. Carcinogenesis 1992;13: 877-81.
3. Kang H, Konishi C, Kuroki T, Huh N. Detection of O6-methylguanine, O4-methylthymine and O4-ethylthymine in human liver and peripheral blood leukocyte DNA. Carcinogenesis 1995;16:1277-80.
4. Szyfter K, Hemminki K, Szyfter W, Szmeja Z, Banaszewski J, Pabiszc- zak M. Tobacco smoke-associated N7-alkylguanine in DNA of larynx tissue and leucocytes. Carcinogenesis 1996;17:501-6.
5. Mustonen R, Schoket B, Hemminki K. Smoking-related DNA adducts: 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA. Carcinogenesis 1993;14:151-4.
6. Mustonen R, Hemminki K. 7-Methylguanine levels in DNA of smokers' and non-smokers' total white blood cells, granulocytes and lymphocytes. Carcinogenesis 1992;13:1951 -5.
7. Bartsch H, Ohshima H, Pignatelli B, Calmels SHuman exposure to endogenous N-nitroso compounds: quantitative estimates in subjects at high risk for cancer of the oral cavity, oesophagus, stomach and urinary bladder. Cancer Surv 1989;8:335-62.
8. Rossi SC, Conrad M, Voigt JM, Topal M. Excision repair of O6- methylguanine synthesized at the rat H-ras N-methyl-N-nitrosourea activation site and introduced intoEscherichia coli. Carcinogenesis 1989;10:373-7.
9. Tan HB, Swann PF, Chance EM. Kinetic analysis of the coding properties of O6-methylguanine in DNA-the crucial role of the conformation of phosphodiester bond. Biochemistry 1994;33:5335-46.
10. Pletsa V, Troungos C, Souliotis VL, Kyrtopoulos SA Comparative study of mutagenesis by O6-methylguanine in the human Ha-ras oncogene in E. coli and in vitro. Nucleic Acids Res 1994;22:3846-53.
11. Mirsalis JC, Monforte JA, Winegan RA. Transgenic animal models for measuring mutations in vitro. Crit Rev Toxicol 1994;24:255-80.
12. Swenberg JA, Bedell MA, Billings KC, Umbenhauer DR, Pegg AE. Cell-specific differences in O6-alkylguanine DNA repair activity during continuous exposure to carcinogen. Proc Natl Acad Sci USA 1982; 79:5499-502.
13. Povey AC, Badawi AF, Cooper DP, et al. DNA alkylation and repair in the large bowel: animal and human studies. J Nutr 2002;132:3518S-21S.
14. Wu JY, Wang J, Lai JC, et al. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status. Ann Surg Oncol 2008;15:3272-7.
15. Wolf P, Hu YC, Doffek K, Sidransky D, Ahrendt SA. O(6)-Methylgua- nine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer. Cancer Res 2001;61:8113-7.
16. Pegg AE. Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 1990;50:6119-29.
17. Kyrtopoulos SA. DNA adducts in humans after exposure to methylat- ing agents. Mutat Res 1998;405:135-43.
18. Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 1995;93:17-48.
19. Foiles PG, Miglietta LM, AkerkarS A, Everson RB, Hecht SS. Detection of O6-methyldeoxyguanosine in human placental DNA. Cancer Res 1988;48:4184-88.
20. Kang H, Konishi C, Kuroki T, Huh NA. A highly sensitive and specific method for quantitation of O-alkylated DNA adducts and its application to the analysis of human tissue DNA. Environ Health Perspect 1993;99:269-71.
21. Haque K, Cooper DP, van Delft JH, Lee SM, Povey AC. Accurate and sensitive quantitation of N7-methyldeoxyguanosine-3'-monophosphate by 32P-postlabeling and storage-phosphor imaging. Chem Res Toxicol 1997;10:660-66.
22. The EUROGAST Study Group. O6-Methylguanine in blood leucocyte DNA: an association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of severe chronic atrophic gastritis. Carcinogenesis 1994;15:1815-20.
23. Georgiadis P, Samoli E, Kaila S, Katsouyanni K, Kyrtopoulos SA. Ubiquitous presence of O6-methylguanine in human peripheral and cord blood DNA. Cancer Epidemiol Biomarkers Prev 2000;9:299-305.
24. Souliotis VL, Kyrtopoulos SA. A novel, sensitive assay for O6-methyl- and O6-ethylguanine in DNA, based on repair by the enzyme O6- alkylguanine-DNA- alkyltransferase in competition with an oligonu- cleotide containing O6-methylguanine. Cancer Res 1989;49:6997-7001.
25. Merlo DF, Wild CP, Kogevinas M, Kyrtopoulos S, Kleinjans J; New-Generis Consortium. New Generis: a European study on maternal diet during pregnancy and child health. Cancer Epidemiol Biomarkers Prev 2009;18:5-10.
26. Hecht SS. DNA adduct formation from tobacco-specific nitrosamines. Mutat Res 1999;424:127-42.
27. Peterson LA, Hecht SS. O6-Methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res 1991;51:5557-64.
28. Carmella SG, Akerkar S, Hecht SS. Metabolites of the tobacco- specific nitroamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res 1993;53:721-4.
29. Hoffmann D, Melikian AA, Wynder EL. Scientific challenges in environmental carcinogenesis. Prev Med 1996;25:14-22.
30. Mijal RS, Thomson NM, Fleischer NL, et al. The repair of the tobacco specific nitrosaminederived adduct O6-(4-oxo-4-(3-pyridyl)butyl)gua-nine by O6-alkylguanine-DNA alkyltransferase variants. Chem Res Toxicol 2004;17:424-34.
31. Sandercock LE, Hahn JN, Li L, et al. Mgmt deficiency alters the in vivo mutational spectrum of tissues exposed to the tobacco carcinogen 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis 2008;29:866-74.
32. Divi RL, Beland FA, Fu PP, et al. Highly sensitive chemiluminescence immunoassay for benzo(a)pyrene-DNA adducts: validation by comparison with other methods, and use in human biomonitoring. Carci- nogenesis 2002;23:2043-9.
33. Aquilina G, Biondo R, Dogliotti E, Bignami M. Genetic consequences of tolerance to methylation DNA damage in mammalian cells. Carci-nogenesis 1993;14:2097-103.
34. Kyrtopoulos SA, Swann PF. The use of radioimmunoassay to study the formation and disappearance of O6-methylguanine in mouse liver satellite and main-band DNA following dimethylnitrosamine administration. J Cancer Res Clin Oncol 1980;98:127-38.